Our laboratory is working to determine how genetic and epigenetic alterations collaborate to promote the transformation of myeloid malignancies by utilizing comprehensive approaches (e.g. genetically modified mice, CRISPR/Cas9 genome editing, and sequencing analysis such as ChIP-seq, ATAC-seq, and Bisulfate-seq). Several areas of current investigation in the lab include:
Link to a complete list of Goro Sashida's publications.